|
CN112159351A
|
|
Preparation method of multi-target antitumor drug
|
|
CN111358773A
|
|
Peramivir dry powder inhalant and preparation method thereof
|
|
CN112174955A
|
|
2-substituted-5-hexahydropyridazinone-4-carboxylic acid amine derivative and application thereof
|
|
CN112174956A
|
|
2-substituted-5-hexahydropyridazinone-4-carboxylic ester derivative and application thereof
|
|
CN110051636A
|
|
Simvastatin dispersible tablets
|
|
CN109771398A
|
|
A kind of Peramivir solution-type inhalant and preparation method thereof
|
|
CN107652228A
|
|
Anti- kidney fibrosis medicine 1（Substituted benzyl）The synthetic method of 5 trifluoromethyl 2 (1H) pyridonium salt hydrochlorates
|
|
CN107663167A
|
|
1‑（Substituted benzyl）The crystal formation and preparation method of 5 trifluoromethyl 2 (1H) pyridonium salt hydrochlorates
|
|
CN105924390A
|
|
Synthesis method of metafenib
|
|
CN105198827A
|
|
Synthetic method of peramivir intermediate
|
|
CN105085328A
|
|
Synthetic method for peramivir trihydrate
|
|
CN105061471A
|
|
Synthesis method of cefotiam hexetil hydrochloride with characteristic of low solvent residue
|
|
CN104873474A
|
|
Methanesulfonic acid dabigatran oral solid preparation
|
|
CN104829511A
|
|
Synthesizing process of Ezetimibe
|
|
CN102716072A
|
|
Method for preparing ciprofloxacin lactate sodium chloride injection
|
|
CN102697747A
|
|
Dispersible tablet of cefuroxime axetil
|
